製药及生物製药实验室设备市场

药理学和新治疗药物的开发对于维持人们的健康和长寿发挥着重要作用。从治疗擦伤和瘀伤等基本疾病到治疗复杂的癌症和罕见疾病，这个行业的重要性怎么强调都不为过。然而，要创造理想的治疗方法并不容易。必须识别该疾病，并且必须在早期阶段开始调查以确定导致该疾病的原因。这是治疗开发开始的地方，也是代谢途径和蛋白质标靶等关键领域的研究开始的地方，它们的相互作用可能有助于改善疾病。随后是生物和无机材料的发展。

这些药物和治疗方法在日益先进的平台上进行了有效性和安全性测试，为研究人员提供了更准确的回馈。然后，最好的候选药物在临床前研究、临床试验和转化研究中进行测试，获得监管部门的批准，并经过严格的QA/QC 流程，然后才能最终製造和销售。为了获得有关药物性质、交互作用、作用机制、副作用、递送方法、功效、製造一致性等的准确资料，必须以准确的方式进行测试。

所有药物开发的中心都是进行研究和开发的製药、生物技术和生物製药公司。分析和生命科学设备的大部分需求来自于新疗法上市的主要商业受益者公司。这些公司经常利用合约研究组织和学术机构等公共机构作为研发过程中的合作者。这些组织在当地监管框架内共同开发治疗方法，以满足世界人口日益成长的医疗保健需求。

该框架中的另一个重要合作伙伴是为快速发展的製药/生物技术产业提供设备、耗材、设备和软体解决方案的供应商网路。製药/生物市场的未来成长将受到新的治疗方式的推动，这些方式更加针对疾病，效果更好，研究和生产时间更短，并且更加依赖患者个体化治疗。这将导致更高的价格以及特定的资本和基础设施要求，导致更加依赖 CRO 和 CMO 来提供高通量筛选、自动化、专业知识和扩大资源。

本报告考察了製药和生物製药实验室设备市场，详细介绍了製药/生物製药领域使用的关键技术，涵盖八类55项技术。未来五年的需求预测将依技术、领域、地区和处理类型进行呈现。它还着重于对药物发现阶段、治疗重点以及治疗药物开发中面临的挑战的见解。

目次

简介

• 报告背景
• 范围和定义
• 製药/生物产业的背景

市场需求

• 总体需求
• 生命科学设备
• 色谱法
• 质量分析
• 实验室自动化
• 原子分光法
• 生物加工
• 成像
• 其他

顶级供应商

附录

Pharmacology and the development of novel therapeutics is an important part of keeping people healthy and long living. From treating basic ailments like scrapes and bruises, to tackling complex cancers and rare diseases, the importance of this industry can't be overstated. However, creating an ideal therapeutic is not a strait forward process. An illness must be identified, and an early stage of research begins to determine what causes that illness. From here, the development of treatment begins, starting with the study of metabolic pathways, protein targets, and other key areas that may, when interacted with, help correct the ailment. The development of substances, both biological and inorganic, then proceeds. These drugs and treatments are tested for both efficacy and safety, on increasingly advanced platforms that offer more precise feedback for researchers. The best of these drug candidates are then tested in preclinical and clinical trials, translational research, and, after receiving regulatory approval, are finally manufactured and distributed, with rigorous QA/QC processes in place. Due to the nature of drugs and their interactions, mechanisms of action, side effects, the method of delivery, it's efficacy, consistency in manufacturing, and more all must be tested using precise methods to generate accurate data. The instruments covered in this report are the primary tools for conducting that research and form the critical infrastructure for pharmaceutical and biotherapeutic compounds. Further, innovations in the instruments, software controlling them, and analysis methods will further drive new biotherapeutics and drug formulations that are key to the success of the industry.

At the heart of all drug development are the pharmaceutical, biotech, and biopharmaceutical companies conducting research and development. They account for the majority of demand for analytical and life science instruments, as they are the main commercial benefactors of new therapeutics that are brought to market. These companies will often utilize contract research organizations and public sector organizations such as academia as collaborators in R&D processes. Together, these organizations work within regional regulatory frameworks to create therapeutics to meet the growing healthcare needs of the global population. Another key partner in this framework is network of suppliers that provide instruments, consumables, equipment, and software solutions to the fast-growing pharma/bio landscape. Future growth in the pharma/bio marketplace will be driven by new therapeutic modalities that are more specific to certain disease, delivered in better ways, with faster research and production timelines, and an increased reliance on personalization to patients. The resulting price tag and need for specific capital and infrastructure will further reliance on high throughput screening, automation, and reliance on CROs and CMOs that provide expertise and scale-up resources.

The SDi "Lab Instrumentation Markets for Pharmaceuticals & Biopharmaceuticals, 2024" report is an in-depth examination of the major technologies used in the pharma/bio sector, encompassing 55 techniques in 8 categories. The report examines historical growth and provides forecasts for demand over the next five years, segmented by technique, sector, region, and therapeutic type. This report focuses on delivering insights into phases of discovery, therapeutic focus, and the challenges being faced in therapeutics development.

Report Overview:

Technology categories included in this report are:

Top Vendors include:

Table of Contents

Introduction

• Report Background
• Scope & Definitions
• Background on the Pharma/Bio Sector

Market Demand

• Overall Demand
• Life Science Instrumentation
• Chromatography
• Mass Spectrometry
• Lab Automation
• Atomic Spectroscopy
• Bioprocessing
• Imaging
• Other Techniques

Appendix

• Recent & Upcoming Reports from SDi